Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers

被引：0
|
作者：
Heidrun Gevensleben
Verena Bossung
Alfons Meindl
Barbara Wappenschmidt
Nikolaus de Gregorio
Ana Osorio
Atocha Romero
Reinhard Buettner
Birgid Markiefka
Rita Katharina Schmutzler
机构：
[1] University Hospital Bonn,Institute of Pathology
[2] University Hospital of Cologne,Molecular Oncology, Department of Obstetrics Gynecology
[3] University Hospital of Luebeck,Department of Obstetrics and Gynecology
[4] Klinikum rechts der Isar der Technischen Universitaet Muenchen,Department of Obstetrics and Gynecology, Division of Tumor Genetics
[5] University Hospital Ulm,Department of Obstetrics and Gynecology
[6] Spanish National Cancer Research Centre,Human Genetics Group, Human Cancer Genetics Programme
[7] Hospital Clínico San Carlos,Medical Oncology Department
[8] University Hospital of Cologne,Institute of Pathology
来源：
Virchows Archiv | 2014年 / 465卷
关键词：
Breast Cancer; Ovarian Cancer; PARP Inhibitor; Ovarian Cancer Case; Characteristic Pathological Feature;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：365 / 369
页数：4
相关论文
共 50 条
  • [1] Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers
    Gevensleben, Heidrun
    Bossung, Verena
    Meindl, Alfons
    Wappenschmidt, Barbara
    de Gregorio, Nikolaus
    Osorio, Ana
    Romero, Atocha
    Buettner, Reinhard
    Markiefka, Birgid
    Schmutzler, Rita Katharina
    VIRCHOWS ARCHIV, 2014, 465 (03) : 365 - 369
  • [2] RAD51C germline mutations in breast and ovarian cancer patients
    Mohammad R Akbari
    Patricia Tonin
    William D Foulkes
    Parviz Ghadirian
    Marc Tischkowitz
    Steven A Narod
    Breast Cancer Research, 12
  • [3] RAD51C germline mutations in breast and ovarian cancer patients
    Akbari, Mohammad R.
    Tonin, Patricia
    Foulkes, William D.
    Ghadirian, Parviz
    Tischkowitz, Marc
    Narod, Steven A.
    BREAST CANCER RESEARCH, 2010, 12 (04):
  • [4] Germline RAD51C mutations in ovarian cancer susceptibility
    Coulet, F.
    Fajac, A.
    Colas, C.
    Eyries, M.
    Dion-Miniere, A.
    Rouzier, R.
    Uzan, S.
    Lefranc, J-P
    Carbonnel, M.
    Cornelis, F.
    Cortez, A.
    Soubrier, F.
    CLINICAL GENETICS, 2013, 83 (04) : 332 - 336
  • [5] RAD51C and RAD51D germline mutations are associated to susceptibility to multiple cancers
    Boni, Jacopo
    Idani, Aida
    Weber, Evan
    Tomiak, Eva
    Foulkes, William
    el Haffaf, Zaki
    Rivera, Barbara
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 426 - 426
  • [6] Germline RAD51C mutations confer susceptibility to ovarian cancer
    Loveday, Chey
    Turnbull, Clare
    Ruark, Elise
    Xicola, Rosa Maria Munoz
    Ramsay, Emma
    Hughes, Deborah
    Warren-Perry, Margaret
    Snape, Katie
    Eccles, Diana
    Evans, D. Gareth
    Gore, Martin
    Renwick, Anthony
    Seal, Sheila
    Antoniou, Antonis C.
    Rahman, Nazneen
    NATURE GENETICS, 2012, 44 (05) : 475 - 476
  • [7] Germline RAD51C mutations confer susceptibility to ovarian cancer
    Alfons Meindl
    Katharina Eirich
    Stefanie Engert
    Alexandra Becker
    Daniela Endt
    Nina Ditsch
    Rita K Schmutzler
    Detlev Schindler
    Nature Genetics, 2012, 44 : 476 - 476
  • [8] Germline RAD51C mutations confer susceptibility to ovarian cancer
    Chey Loveday
    Clare Turnbull
    Elise Ruark
    Rosa Maria Munoz Xicola
    Emma Ramsay
    Deborah Hughes
    Margaret Warren-Perry
    Katie Snape
    Diana Eccles
    D Gareth Evans
    Martin Gore
    Anthony Renwick
    Sheila Seal
    Antonis C Antoniou
    Nazneen Rahman
    Nature Genetics, 2012, 44 : 475 - 476
  • [9] Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan
    Rashid, Muhammad U.
    Muhammad, Noor
    Faisal, Saima
    Amin, Asim
    Hamann, Ute
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (03) : 775 - 784
  • [10] Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan
    Muhammad U. Rashid
    Noor Muhammad
    Saima Faisal
    Asim Amin
    Ute Hamann
    Breast Cancer Research and Treatment, 2014, 145 : 775 - 784
12345